Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

EBR/ALEMS stock hub

EBR/ALEMS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EBR/ALEMSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

20.7M

Euronext Brussels

Market data

Price

Recent price action with selectable time range.

EBR/ALEMSEBR/ALEMS

—

Loading chart…

In the news

Latest news · EBR/ALEMS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E11.3

P25 n/aP50 n/aP75 n/a

ROE16.4

P25 n/aP50 n/aP75 n/a

ROIC9.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EBR/ALEMS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

201

Groups with data

Currency

EUR

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Belgium
Country code	BE
Employees	123
Employees Change	1%
Employees Change Percent	0.82
Enterprise value	EUR 34.5M
Exchange	Euronext Brussels
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	BE0974497290
Last refreshed	2026-05-10
Market cap	EUR 20.7M
Price	EUR 4.9
Price currency	EUR
Rev Per Employee	429,300.81x
Sector	Healthcare
Sic	2836
Symbol	ebr/ALEMS
Website	https://www.dms-imaging.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	8.87%
EV Earnings	18.76x
EV/EBIT	13.8x
EV/EBITDA	9.67x
EV/FCF	13.84x
EV/Sales	0.65x
FCF yield	12.03%
P/B ratio	1.72x
P/E ratio	11.27x
P/S ratio	0.39x
PE Ratio3 Y	23.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	4.74%
EBITDA Margin	5.56%
FCF margin	4.72%
Gross margin	36.02%
Gross Profit	EUR 19M
Gross Profit Growth	7.82%
Gross Profit Growth Q	16.55%
Gross Profit Growth3 Y	7.12%
Gross Profit Growth5 Y	5.16%
Net Income	EUR 1.8M
Net Income Growth	237%
Net Income Growth Q	362.5%
Net Income Growth Quarters	3%
Net Income Growth Years	3%
Pretax Margin	3.61%
Profit Margin	3.48%
Profit Per Employee	EUR 14,959
Profitable Years	2
ROA	3.12
Roa5y	0.41
ROCE	9.69
ROE	16.43
Roe5y	-9.23
ROIC	9.35
Roic5y	1.09

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-10.92%
Cagr3y	-12.1%
Cagr5y	-49.93%
EPS Growth	237
EPS Growth Q	362.5
EPS Growth Quarters	3
EPS Growth Years	9
OCF Growth	110.37%
OCF Growth Q	191.7%
OCF Growth3 Y	105.32%
OCF Growth5 Y	65.34%
Revenue Growth	10.21x
Revenue Growth Q	13.48x
Revenue Growth Quarters	4x
Revenue Growth Years	3x
Revenue Growth3 Y	6.33x
Revenue Growth5 Y	5.78x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.05
Assets	EUR 51.8M
Cash	EUR 4.9M
Current Assets	EUR 36.5M
Current Liabilities	EUR 26M
Debt	EUR 18.7M
Debt EBITDA	EUR 5.23
Debt Equity	EUR 1.55
Debt FCF	EUR 7.49
Equity	EUR 12.1M
Interest Coverage	3.39
Liabilities	EUR 39.7M
Long Term Assets	EUR 15.3M
Long Term Liabilities	EUR 13.7M
Net Cash	EUR -13.8M
Net Cash By Market Cap	EUR -66.5
Net Debt EBITDA	EUR 4.7
Net Debt Equity	EUR 1.14
Net Debt FCF	EUR 5.53
Tangible Book Value	EUR 11.6M
Tangible Book Value Per Share	EUR 2.73
WACC	4.52

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.4
Inventory Turnover	2.48
Net Working Capital	EUR 14.5M
Quick ratio	0.71
Working Capital	EUR 10.5M
Working Capital Turnover	EUR 4.72

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-10.91%
200-day SMA	4.98
3Y total return	-32.1%
50-day SMA	5.07
50-day SMA vs 200-day SMA	50over200
5Y total return	-96.85%
All Time High	2,956.4
All Time High Change	-99.83%
All Time High Date	2017-03-01
All Time Low	0.7
All Time Low Change	596.02%
All Time Low Date	2023-09-01
ATR	0.09
Beta	0.16
Beta1y	0.48
Beta2y	0.21
Ch YTD	-5.77
High	4.9
High52	5.75
High52 Date	2025-09-19
High52ch	-14.78%
Low	4.9
Low52	4.2
Low52 Date	2025-09-12
Low52ch	16.67%
Ma50ch	-3.31%
Price vs 200-day SMA	-1.67%
RSI	44.47
RSI Monthly	32.2
RSI Weekly	45.04
Sharpe ratio	0.3x
Sortino ratio	0.51
Tr YTD	-5.77
Tr1m	-9.26%
Tr1w	-6.67%
Tr3m	-7.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 2.5M
Operating Income Growth	29.59
Operating Income Growth Q	71.29
Operating margin	4.74

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	-1,449,000
Shares Institutions	0.02%
Shares Out	4,231,839
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 2.5M
Average Volume	24.55x
Bv Per Share	2.85
CAPEX	EUR -2.9M
Ch1m	-9.26
Ch1w	-6.67
Ch1y	-10.91
Ch3m	-7.88
Ch3y	-32.1
Ch5y	-96.85
Ch6m	-2
Change	0%
Change From Open	0
Close	4.9
Days Gap	0
Depreciation Amortization	433,000
Dollar Volume	19.6
Earnings Date	2026-05-12
EBIT	EUR 2.5M
EBITDA	EUR 2.9M
EPS	EUR 0.43
F Score	7
FCF	EUR 2.5M
FCF EV Yield	7.22x
FCF Per Share	EUR 0.59
Financing CF	-2,185,000
Fiscal Year End	December
Founded	1,979
Graham Number	5.27969
Graham Upside	7.75
Income Tax	EUR 65,000
Investing CF	-2,881,000
Is Primary Listing	1
Last Earnings Date	2025-12-18
Last Report Date	2025-12-31
Last Split Date	2024-12-27
Last Split Type	Reverse
Ma150	5.06
Ma150ch	-3.24%
Ma20	4.99
Ma20ch	-1.86%
Net CF	309,000
Next Earnings Date	2026-05-12
Open	4.9
P FCF Ratio	8.31
P OCF Ratio	3.86
Ppne	3,909,000
Price Date	2026-05-05
Price EBITDA	EUR 7.07
Ptbv Ratio	1.8
Relative Volume	0.16x
Revenue	52,804,000x
Tax By Revenue	0.12x
Tax Rate	3.41%
Tr6m	-2%
Volume	4

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does EBR/ALEMS pay a dividend?

Capital-return profile for this ticker.

Performance

EBR/ALEMS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns EBR/ALEMS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.0%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

EBR/ALEMS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.5

Neutral momentum band

Price vs 200-day MA

-1.7%

50/200-day relationship not available

Beta (5Y)

0.16

Less volatile than the market

Sharpe ratio

0.30

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EBR/ALEMS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ebr/ALEMS stock rating?

ebr/ALEMS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ebr/ALEMS analysis?

The full report lives at /stocks/ebr/ALEMS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ebr/ALEMS?

The latest report frames ebr/ALEMS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ebr/ALEMS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.